Invention Application
- Patent Title: PRIMARY BREAST EPITHELIAL CELL CULTURE MEDIUM, CULTURE METHOD AND USE THEREOF
-
Application No.: US17775106Application Date: 2019-11-18
-
Publication No.: US20220389379A1Publication Date: 2022-12-08
- Inventor: Qingsong LIU , Feiyang LIU , Husheng MEI , Wenchao WANG , Ming ZHAO , Zongru JIANG , Tao REN , Li WANG
- Applicant: PRECEDO PHARMACEUTICALS CO., LTD
- Applicant Address: CN Hefei, Anhui Province
- Assignee: PRECEDO PHARMACEUTICALS CO., LTD
- Current Assignee: PRECEDO PHARMACEUTICALS CO., LTD
- Current Assignee Address: CN Hefei, Anhui Province
- Priority: CN201911085968.8 20191108
- International Application: PCT/CN2019/119116 WO 20191118
- Main IPC: C12N5/071
- IPC: C12N5/071 ; C12N5/09 ; G01N33/50

Abstract:
Provided is a culture medium containing amphiregulin for culturing primary breast epithelial cells and a culture method involving using the medium. In the culturing method, primary cells are cultured on a culture vessel coated with an extracellular matrix gel by using the culture medium, and the primary cells grow on the culture vessel, which has been coated with the extracellular matrix gel, and proliferate rapidly under the combined action of nutrient factors and an extracellular matrix contained in the primary cell culture medium. The cell model obtained by the primary cell culture medium and the primary cell culture method can be used for the evaluating the efficacy of and screening drugs.
Information query